AA severity and previous hair regrowth were significant predictors associated with a better outcome ([adjusted OR = 3.415; P = .026] and [adjusted OR = 5.312; P = .010], respectively).

Oral tofacitinib (Xeljanz), a JAK inhibitor, helped regrow hair in three quarters of pediatric patients with alopecia areata (AA) ... ICD-10-CM Codes Debut for Two Hair Loss Disorders; ...

Studies examined JAK inhibitors, mostly used in monotherapy with tofacitinib, for hair loss. Tofacitinib showed strong efficacy (P < .001). Efficacy of baricitinib was achieved in patients with ...

Seventy-five percent of patients with moderate to severe alopecia areata -- an autoimmune disease that causes patchy, and less frequently, total hair loss -- had significant hair regrowth after ...

Both Rogaine and Xeljanz were found to have an effect on alopecia accidentally, as people taking the drugs experienced renewed hair growth. However, taking JAK inhibitors to treat alopecia would not ...

Many people with thinning hair turn to minoxidil., commonly sold under the brand name Rogaine. But if it doesn’t seem to be working, one doctor has some tips for getting better results.

The drug, made by Pfizer, is called tofacitinib citrate and has been proven to sometimes treat psoriasis in humans and alopecia universalis in mice, but has never been used to grow hair in humans.